Neuroleptic-induced dystonia: incidence and risk factors

By Ballerini M.   Bellini S.   Niccolai C.   Pieroni V.   Ferrara M.  

European Psychiatry, Vol. 17, Iss. 6, 2002-10 ,pp. : 366-368

Elsevier

Access to resources Recommend Favorite

Risperidone treatment of neuroleptic-induced tardive extrapyramidal symptoms

By Suenaga Takami   Tawara Yasutaka   Goto Shinichiro   Kouhata Shin-Ichi   Kagaya Ariyuki   Horiguchi Jun   Yamanaka Yusuke   Yamawaki Shigeto  

International Journal of Psychiatry in Clinical Practice, Vol. 4, Iss. 3, 2000-09 ,pp. : 241-243

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Safety and efficacy of long-term low-dose clozapine aftercare treatment in a patient with learning difficulties who suffered from neuroleptic malignant syndrome

By Reznik Ilya   Spivak Baruch   Melman Rima   Kotler Moshe   Weizman Abraham   Mester Roberto  

International Journal of Psychiatry in Clinical Practice, Vol. 6, Iss. 2, 2002-06 ,pp. : 121-123

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Acute dystonia induced by the combination of midodrine and perphenazine

By Castrioto Anna  

Journal of Neurology, Vol. 255, Iss. 5, 2008-05 ,pp. : 767-768

Springer Publishing Company

Access to resources Recommend Favorite

Neuroleptic-induced extrapyramidal symptoms are accompanied by cognitive dysfunction in schizophrenia

By Krausz M.   Moritz S.H.   Naber D.   Lambert M.   Andresen B.  

European Psychiatry, Vol. 14, Iss. 2, 1999-04 ,pp. : 84-88

Elsevier

Access to resources Recommend Favorite